CHMP recommends Novartis drug Afinitor® for EU approval
18:00 EDT 21 Jun 2012 | PharmaNews.EU
Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Afinitor® (everolimus) tablets*, in combination with exemestane, for the treatment of hormone..
Original Article: CHMP recommends Novartis drug Afinitor® for EU approval
More From BioPortfolio on "CHMP recommends Novartis drug Afinitor® for EU approval"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
